Pfizer
PFE
NZ$40.06
Share price
-0.73%
Change (1 day)
-8.62%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Earnings for Pfizer (PFE)
Earnings in 2025 (TTM): NZ$17.08 Billion
According to Pfizer's latest financial reports the company's current earnings are NZ$62.46 Billion. In 2024 the company made an earning of NZ$18.27 Billion, an increase over its 2023 earnings that were of NZ$5.37 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Pfizer from 1984 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | NZ$17.08 B | -6.51% |
| 2024 | NZ$18.27 B | 240.16% |
| 2023 | NZ$5.37 B | -90.92% |
| 2022 | NZ$59.14 B | 38.55% |
| 2021 | NZ$42.68 B | 390.37% |
| 2020 | NZ$8.70 B | -72.51% |
| 2019 | NZ$31.66 B | 45.88% |
| 2018 | NZ$21.70 B | -2.76% |
| 2017 | NZ$22.32 B | 42.35% |
| 2016 | NZ$15.68 B | -6.17% |
| 2015 | NZ$16.71 B | -25.26% |
| 2014 | NZ$22.36 B | -20.61% |
| 2013 | NZ$28.16 B | 30.63% |
| 2012 | NZ$21.56 B | -7.09% |
| 2011 | NZ$23.20 B | 26.97% |
| 2010 | NZ$18.27 B | -8.23% |
| 2009 | NZ$19.91 B | -18.58% |
| 2008 | NZ$24.46 B | 43.94% |
| 2007 | NZ$16.99 B | -27.63% |
| 2006 | NZ$23.48 B | -2.18% |
| 2005 | NZ$24.00 B | -14.23% |
| 2004 | NZ$27.99 B | 58.49% |
| 2003 | NZ$17.66 B | -10.05% |
| 2002 | NZ$19.63 B | 8.78% |
| 2001 | NZ$18.04 B | 28.9% |
| 2000 | NZ$14.00 B | 47.78% |
| 1999 | NZ$9.47 B | 59.92% |
| 1998 | NZ$5.92 B | 9.58% |
| 1997 | NZ$5.40 B | 8.91% |
| 1996 | NZ$4.96 B | 19.21% |
| 1995 | NZ$4.16 B | 28.39% |
| 1994 | NZ$3.24 B | 72.41% |
| 1993 | NZ$1.88 B | -20.74% |
| 1992 | NZ$2.37 B | 15.15% |
| 1991 | NZ$2.06 B | 18.95% |
| 1990 | NZ$1.73 B | 8.84% |
| 1989 | NZ$1.59 B | -4.32% |
| 1988 | NZ$1.66 B | 7.56% |
| 1987 | NZ$1.54 B | -1.97% |
| 1986 | NZ$1.57 B | 9.83% |
| 1985 | NZ$1.43 B | 4.84% |
| 1984 | NZ$1.37 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Merck MRK | NZ$35.27 B | 107.43% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$45.06 B | 165.04% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$10.04 B | -40.93% | 🇺🇸 USA |
 Eli Lilly LLY | NZ$22.36 B | 31.52% | 🇺🇸 USA |
 Novartis NVS | NZ$24.53 B | 44.26% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | NZ$8.89 B | -47.67% | 🇬🇧 UK |
 Amgen AMGN | NZ$10.93 B | -35.69% | 🇺🇸 USA |
 Abbott Laboratories ABT | NZ$12.09 B | -28.88% | 🇺🇸 USA |
 AstraZeneca AZN | NZ$18.04 B | 6.09% | 🇬🇧 UK |